Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Cytomegalovirus Infection

Free Subscription Articles published in Clin Transplant Retrieve available abstracts of 18 articles: HTML format

Single Articles

November 2022
1. VAN AELST LNL, Droogne W, Voros G, Van Cleemput J, et al
   Combination Prophylaxis in CMV high risk heart transplant recipients - a single centre experience.
   Clin Transplant. 2022 Nov 14:e14848. doi: 10.1111/ctr.14848.
   PubMed     Abstract available
   
   
   
2. JORGENSON MR, Kleiboeker HL, Astor BC, Gentry AC, et al
   Seasonal variation of cytomegalovirus disease in kidney transplant recipients.
   Clin Transplant. 2022 Nov 10:e14852. doi: 10.1111/ctr.14852.
   PubMed     Abstract available
   
   
   October 2022
3. ZANG S, Zhang X, Niu J, Das BB, et al
   Impact of induction therapy on cytomegalovirus infection and post-transplant outcomes in pediatric heart transplant recipients receiving routine antiviral prophylaxis.
   Clin Transplant. 2022 Oct 19:e14836. doi: 10.1111/ctr.14836.
   PubMed     Abstract available
   
   
   September 2022
4. GOLOB S, Batra J, DeFilippis EM, Uriel M, et al
   Letermovir for Cytomegalovirus Prophylaxis in High Risk Heart Transplant Recipients.
   Clin Transplant. 2022 Sep 10:e14808. doi: 10.1111/ctr.14808.
   PubMed     Abstract available
   
   
   March 2022
5. HIDAKA Y, Goto N, Yamanaga S, Kinoshita K, et al
   Two-year outcomes of low-exposure extended-release tacrolimus and mycophenolate mofetil regimen in de novo kidney transplantation: A multi-center randomized controlled trial.
   Clin Transplant. 2022 Mar 28:e14655. doi: 10.1111/ctr.14655.
   PubMed     Abstract available
   
   
   
6. NGUYEN A, Finci L, Berney T, Tonoli D, et al
   Letermovir for cytomegalovirus primary prophylaxis in a multiple abdominal/ small bowel transplant recipient.
   Clin Transplant. 2022 Mar 2:e14624. doi: 10.1111/ctr.14624.
   PubMed    
   
   
   January 2022
7. MEHTA RB, Shimko K, Zhang X, Puttarajappa C, et al
   Rabbit antithymocyte globulin dose and early subclinical and clinical rejections in kidney transplantation.
   Clin Transplant. 2022 Jan 9:e14582. doi: 10.1111/ctr.14582.
   PubMed     Abstract available
   
   
   
8. BRAR S, Berry R, Raval AD, Tang Y, et al
   Outcomes among CMV-mismatched and highly sensitized kidney transplants recipients who develop neutropenia.
   Clin Transplant. 2022 Jan 4:e14583. doi: 10.1111/ctr.14583.
   PubMed     Abstract available
   
   
   December 2021
9. AFZAL A, Alam A, van Zyl JS, Zafar H, et al
   Observed Elevated Donor-Derived Cell Free DNA in Orthotopic Heart Transplant Recipients Without Clinical Evidence of Rejection.
   Clin Transplant. 2021 Dec 4:e14549. doi: 10.1111/ctr.14549.
   PubMed     Abstract available
   
   
   November 2021
10. ORTIZ F, Lempinen M, Aaltonen S, Koivuviita N, et al
    Letermovir treatment for CMV infection in kidney and pancreas transplantation: a valuable option for complicated cases.
    Clin Transplant. 2021 Nov 19:e14537. doi: 10.1111/ctr.14537.
    PubMed     Abstract available
    
    
    July 2021
11. JORGENSON MR, Descourouez JL, Leverson GE, Saddler CM, et al
    A Pilot Study of an Intensified Ganciclovir Dosing Strategy for Treatment of Cytomegalovirus Disease in Kidney and/or Pancreas Transplant Recipients.
    Clin Transplant. 2021 Jul 15. doi: 10.1111/ctr.14427.
    PubMed     Abstract available
    
    
    June 2021
12. RHO E, Naf B, Tf M, Rp W, et al
    Use of Letermovir-Valganciclovir combination as a step-down treatment after Foscarnet for Ganciclovir-resistant CMV infection in kidney transplant recipients.
    Clin Transplant. 2021 Jun 28. doi: 10.1111/ctr.14401.
    PubMed     Abstract available
    
    
    
13. JORGENSON MR, Marka N, Leverson GE, Smith JA, et al
    Valganciclovir Prophylaxis Extension from 3 to 6 Months in High Risk Pancreas Transplant Recipients Does Not Impact Incidence of Cytomegalovirus Infection at 12 months.
    Clin Transplant. 2021 Jun 2:e14379. doi: 10.1111/ctr.14379.
    PubMed     Abstract available
    
    
    May 2021
14. DURST MM, Jorgenson MR, Descourouez JL, Saddler CM, et al
    Bimonthly viral monitoring for late-onset cytomegalovirus infection-Balancing efficacy with patient palatability; A reply to Melgarejo et al.
    Clin Transplant. 2021 May 21:e14348. doi: 10.1111/ctr.14348.
    PubMed    
    
    
    March 2021
15. VEIT T, Pan M, Munker D, Arnold P, et al
    Association of CMV-specific-T-cell immunity and risk of CMV infection in lung transplant recipients.
    Clin Transplant. 2021 Mar 22:e14294. doi: 10.1111/ctr.14294.
    PubMed     Abstract available
    
    
    
16. RAHIMISHAHMIRZADI M, Jevnikar AM, House AA, Luke PP, et al
    Late-onset Allograft Rejection, Cytomegalovirus Infection and Renal Allograft Loss: Is Anti-CMV Prophylaxis Required Following Late-onset Allograft Rejection?
    Clin Transplant. 2021 Mar 13:e14285. doi: 10.1111/ctr.14285.
    PubMed     Abstract available
    
    
    February 2021
17. MELGAREJO I, Jorgensen D, Hariharan S, Puttarajappa CM, et al
    Bimonthly Viral Monitoring for Late-Onset Cytomegalovirus infection in Kidney Transplant Recipients.
    Clin Transplant. 2021 Feb 19:e14259. doi: 10.1111/ctr.14259.
    PubMed     Abstract available
    
    
    January 2021
18. VON STEIN L, Leino AD, Pesavento T, Rajab A, et al
    Antithymocyte induction dosing and incidence of opportunistic viral infections using steroid-free maintenance immunosuppression.
    Clin Transplant. 2021;35:e14102.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: